Why Did GE Vernova Stock Fall Today?

GE Vernova (GEV) shares fell 8.6% after GLJ Research initiated coverage with a Sell rating and $470 target, citing cyclical operations and wind energy losses. The stock is up 29.1% YTD but 25.3% below its 52-week high. Analysts note volatility and market reaction to economic data.

GE Vernova (GEV) shares dropped 8.6% to $874.85 after GLJ Research analyst Gordon Johnson initiated a Sell rating with a $470 target. The company reported strong demand with 116 GW of gas-equipment backlog and reservations, but its GF Score is 15/100, indicating weaker profitability and growth. Investors must assess whether the current valuation reflects future growth.

GE Vernova (GEV) fell 9% to $873.89 after GLJ Research initiated coverage with a Sell rating and $470 target, citing cyclical business concerns. Peers Eaton (ETN) and Quanta Services (PWR) also dropped 7% and 4%, respectively, as the GRID ETF declined 4%. GEV's order book, at $176 billion, has supported its valuation, but the sell note questions its multiple.

GE Vernova (GEV) shares dropped 8.6% to $874.85 after GLJ Research analyst Gordon Johnson initiated a Sell rating with a $470 target, 46.9% below current price. The company reported strong demand with 116 GW of gas-equipment backlog and reservations, but GuruFocus highlights weak fundamentals with a GF Score of 15. Investors must assess whether the current valuation reflects future growth.

GE Vernova Inc. (GEV) reported a significant increase in free cash flow, rising to $9.9 billion in H1 2026 from $1.2 billion a year earlier. The company raised its full-year free cash flow guidance to $11.5-$12.5 billion and revenue guidance to $45.5-$46.5 billion. GEV is using its stronger cash position to return capital to shareholders through share repurchases and dividends. The company is benefiting from strong demand in its Power and Electrification businesses, driving higher orders and rev

GE Vernova (GEV) shares dropped 4.8% in pre-market trading after GLJ Research initiated coverage with a Sell rating and a $470 price target. The company's shares have risen 52% over the past year but have declined 10% in the past month. The broader market also fell, with the S&P 500 down 0.8%.